Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001536368-25-000004

Director acquired 5,534 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kunkel Lori Anne Director 2025-12-04 Option exercise +5,534 $3.75 $20,753 74,200 D
Derivatives
Kunkel Lori Anne Director 2025-12-04 Option exercise · Stock Option (right to buy) −5,534 0 D
Loading xslF345X05/form4-12052025_101227.xml…